Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services.
23andMe To Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million
Headlines
